Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ifos Injectable*


Contraindicated
Congenital malformations

Contraindicated
Ifos Injectable* :
Type Medicine Non Marketed
Originator Holoxan 1g
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Cipla
Responsible Party Cipla Ltd
Origin India
Manufacturer Cipla Ltd
Manufacturing Type G
Origin India
ATC L01AA06

Your comment will appear shortly after approval

Ifos Injectable* :

Revision Date : 17/06/2016


Effect Frequency
Abdominal pain Not known
Acute leukaemia Not known
Acute lymphocytic leukaemia (Acute lymphoblastic leukemia) Not known
Acute respiratory distress syndrome Not known
Agranulocytosis Not known
Alopecia Very Common
Amenorrhoea (amenorrhea) Not known
Aminoaciduria Not known
Amnesia Not known
Anaemia Not known
Anaemia neonatal Not known
Anaphylactic reactions Not known
Angina pectoris Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Arrhythmia Not known
Arrhythmia supraventricular Not known
Arthralgia (Pain joint) (Joint ache) Not known
Asterixis Not known
Atrial fibrillation Not known
Azoospermia Not known
Bone marrow failure (Myelosuppression) Very Common
Bradycardia Not known
Capillary leak syndrome Not known
Cardiac arrest Not known
Cardiac failure Not known
Cardiomyopathy Not known
Cardiotoxicity Uncommon
Catatonia Not known
Chills Not known
Chronic renal insufficiency (Renal failure chronic) Not known
CNS toxicity Not known
Congestive cardiomyopathy Not known
Conjunctivitis Not known
Constipation Not known
Cough Not known
Cystitis haemorrhagic Very Common
Cytolytic hepatitis Not known
Deafness Not known
Decreased appetite Common
Deep vein thrombosis Not known
Delirium Not known
Delusion Not known
Dermatitis Rare
Diarrhoea (Diarrhea) Uncommon
Disseminated intravascular coagulation Not known
Dysarthria Not known
Dyspnoea (dyspnea) Not known
ECG QRS complex abnormal Not known
ECG ST segment abnormal Not known
ECG T wave inversion Not known
Echolalia Not known
Encephalopathy Not known
Enterocolitis Not known
Enuresis Not known
Erythema Not known
Extrapyramidal disorder Not known
Eye irritation Not known
Faecal incontinence Not known
Fanconi syndrome Not known
Fatigue Uncommon
Febrile bone marrow aplasia Not known
Feeling of residual urine Not known
Flushing Not known
Foetal growth restriction Not known
Gait disturbance Not known
Gastroduodenal haemorrhage Not known
General physical health deterioration Not known
Growth retardation Not known
Haematotoxicity Not known
Haematuria (Hematuria) Very Common
Haemolytic anemia Not known
Haemolytic uraemic syndrome (HUS) Not known
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Not known
Hepatotoxicity (liver toxicity) Common
Hyperglycaemia Not known
Hyperhidrosis Not known
Hypersensitivity reactions Not known
Hypertension Not known
Hypocalcaemia Not known
Hypoesthesia Not known
Hypokalaemia Not known
Hypophosphataemia Not known
Hypotension Uncommon
Hypoxia Not known
Ileus Not known
Immunosuppression Not known
Inappropriate antidiuretic hormone secretion (SIADH) Not known
Infection Common
Infection reactivation Common
Infertility Not known
Infusion site reactions Not known
Injection site reaction Not known
Interstitial lung disease Not known
Leucopenia (Leukopenia) Very Common
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Lymphoma Not known
Malaise Not known
Mania Not known
Metabolic acidosis Not known
Methemoglobinemia Not known
Movement disorder Not known
Mucosal ulceration Not known
Multi-organ failure Not known
Muscle twitching (Muscle twitch) Not known
Mutism Not known
Myalgia Not known
Myelodysplastic syndrome Not known
Myocardial haemorrhage Not known
Myocardial infarction Not known
Nail disorders Not known
Nausea Very Common
Nephrogenic diabetes insipidus Not known
Neuralgia Not known
Neuropathy peripheral Not known
Non-Hodgkin's lymphoma Not known
Oedema Not known
Oligospermia Not known
Osteomalacia Not known
Ovarian failure Not known
Ovulation disorder Not known
Pain Not known
Pancreatitis Not known
Panic attack Not known
Paraesthesia (paresthesia) Not known
Paranoia Not known
Perseveration Not known
Phlebitis Common
Pleural effusion Not known
Pneumonitis Not known
Polydipsia Not known
Polyuria Not known
Portal vein thrombosis Not known
Premature atrial contraction Not known
Premature menopause Not known
Pruritus Not known
Pulmonary embolism Not known
Pulmonary fibrosis Not known
Pulmonary hypertension Not known
Pulmonary oedema Not known
Pyrexia Not known
Radiation recall reaction (dermatologic) Not known
Rash papular Rare
Renal cell carcinoma Not known
Renal disorder Very Common
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Very Common
Respiratory failure Not known
Rhabdomyolysis Not known
Rickets Not known
Salivary hypersecretion Not known
Sarcoma Not known
Sepsis (Systemic infection) (Sepsis state) Not known
Septic shock Not known
Skin hyperpigmentation Not known
Skin necrosis Not known
Skin rash Not known
Status epilepticus Not known
Stevens-Johnson syndrome Not known
Stomatitis Uncommon
Swelling face Not known
Thrombocytopenia (Thrombopenia) Very Common
Thyroid cancer Not known
Tinnitus Not known
Tubulointerstitial nephritis Not known
Tumour lysis syndrome Not known
Urinary tract carcinoma in situ Not known
Urine phosphate increased Not known
Urticaria Not known
Vasculitis Not known
Venoocclusive liver disease Not known
Ventricular arrhythmia Not known
Vertigo Not known
Visual impairment Not known
Vomiting Very Common

Different Units By MoH Code

Revision Date : no date

Ifos Injectable*  MoH 2463 :
Form Powder for solution for injection
Packaging Bottle
Package Size Box of 1
Strength 1g
NSSF ✘
Quarantine ✔
Reg. Number 208699/03
Submission date 01/01/2003
Registration Year 2005
Archived Date 02/10/2020


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info